Oppenheimer reiterated its Outperform rating on Oracle ORCL ahead of the company's quarterly earnings report, which is due on Thursday, June 23.
In a research report published today, Oppenheimer states, "We would be buyers of the shares of ORCL ahead of its FY4Q11 results on
Thursday (6/23), as we think the recent pullback in the stock (largely due to macro
issues) combined with reasonable expectations has set up a favorable risk/reward
heading into the print. While the macro environment remains volatile and ORCL is
likely facing pockets of weakness (certain areas of Europe), based on our recent
channel checks, we feel overall demand, especially for Exadata, is still healthy and
should enable it to end FY11 strongly. Additionally, given growing traction for
ORCL's Exadata and Exalogic solutions coupled with margin expansion
opportunities and potential accretive acquisitions, we expect the shares to
outperform peers."
At the moment, Oppenheimer has a price target of $38 placed on the company's stock. On Friday, Oracle added 1.25% to its value to finish the day at $31.18. Its shares lost some value in today's pre-market trading, however, sliding 0.08% to $31.16.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in